Philips aims to compete in wellness tracker market

Cara Livernois | | Health Exec | Precision Medicine

Walking into most hospitals, you’ll be able to see CT scanners or MRI machines all made by Philips. The company is now looking to being healthcare technology closer to home with the release of four new products meant for everyday use, reports The Next Web.

Competing against well-known products like Fitbit and MyFitnessPal, Philips hopes to introduce four new products for people wanting to take hold of their own health. These new products include:

  • A blood pressure monitor that measures diastolic and systolic blood pressure, heart rate and can be worn on both the wrist and arm.
  • The weighing scale that measures weight and can calculate BMI body fat percentage.
  • An in-ear thermometer that can determine body temperature within two seconds.
  • Philips Health Watch, similar to wearable fitness trackers of today the watch can track activity, heart rate, and the sleep patterns. 

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup